Published in Pharmazie on July 01, 2007
Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy. Nanoscale Res Lett (2011) 0.86
Polymeric micelles: nanocarriers for cancer-targeted drug delivery. AAPS PharmSciTech (2014) 0.81
Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria. Biomacromolecules (2011) 0.81
Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond) (2015) 0.79
Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. AAPS J (2014) 0.79
Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations. Mol Pharm (2017) 0.75
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci (1996) 3.83
The potential use of cyclodextrins in parenteral formulations. J Parenter Sci Technol (1989) 1.43
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol (1991) 1.16
DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release (2005) 1.08
Transdermal delivery of macromolecules using skin electroporation. Pharm Res (2000) 1.01
Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm (2013) 1.00
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release (2001) 0.96
Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release (1998) 0.96
In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers. Eur J Pharm Biopharm (1998) 0.95
The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro (2005) 0.92
Topical gene transfer into rat skin using electroporation. Pharm Res (2001) 0.90
Site-specific, sustained release of drugs to the brain. Science (1981) 0.89
The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B. J Pharm Pharmacol (1991) 0.88
Structural studies of loteprednol etabonate and other analogs of prednisolone using NMR techniques. Steroids (1996) 0.87
Transdermal delivery of metoprolol by electroporation. Pharm Res (1994) 0.86
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release (2006) 0.86
Problems of delivery of drugs to the brain. Pharmacol Ther (1982) 0.86
Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm (2006) 0.86
Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis. Carcinogenesis (1983) 0.85
On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem Biol Interact (1991) 0.85
Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release (2007) 0.83
Transfer of phosphatidylcholine facilitated by a component of human plasma. Biochim Biophys Acta (1978) 0.83
Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res (1992) 0.82
Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis. Carcinogenesis (1986) 0.82
A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine. J Forensic Sci (1988) 0.82
Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J Control Release (1998) 0.82
Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res (1997) 0.82
Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze-fracture electron microscopy and differential thermal analysis study. J Investig Dermatol Symp Proc (1998) 0.82
The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. Pharmazie (2004) 0.81
In vitro identification of targeting ligands of human M cells by phage display. Int J Pharm (2010) 0.81
Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann Trop Med Parasitol (1992) 0.81
Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharm Res (1996) 0.80
In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat. Skin Pharmacol Appl Skin Physiol (2003) 0.80
Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. J Control Release (1999) 0.80
Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Pharmazie (2008) 0.80
Peroxidase-catalyzed S-oxygenation: mechanism of oxygen transfer for lactoperoxidase. Biochemistry (1991) 0.80
Factors affecting iontophoretic mobility of metoprolol. J Pharm Sci (1992) 0.80
Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin. J Control Release (2000) 0.80
Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sci (1988) 0.79
High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats. Pharm Res (1988) 0.79
In vivo noninvasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol (1998) 0.79
Nano-emulsions of fluorinated trityl radicals as sensors for EPR oximetry. J Magn Reson (2008) 0.79
Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. J Parenter Sci Technol (1990) 0.79
Transdermal alniditan delivery by skin electroporation. J Control Release (1998) 0.78
Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis. Jpn J Cancer Res (1986) 0.78
Parameters controlling topical delivery of oligonucleotides by electroporation. J Drug Target (1998) 0.78
Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy. J Control Release (2006) 0.78
Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol (1995) 0.78
Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res (1998) 0.78
Modulation of hepatocarcinogenesis. Annu Rev Pharmacol Toxicol (1991) 0.78
Improved brain delivery and in vitro activity of zidovudine through the use of a redox chemical delivery system. AIDS (1995) 0.77
Promoting effect of oxazepam in rat hepatocarcinogenesis. Carcinogenesis (1987) 0.77
Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency. Int J Pharm (2003) 0.77
Usefulness of a novel Caco-2 cell perfusion system II. Characterization of monolayer properties and peptidase activity. Pharmazie (2009) 0.77
Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs. Int J Pharm (2009) 0.77
Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis (1990) 0.77
Antihypertensive activity of redox derivatives of tryptophan. J Med Chem (1990) 0.77
Sustained brain-specific delivery of estradiol causes long-term suppression of luteinizing hormone secretion. J Med Chem (1986) 0.77
Evidence for the reestablishment of copulatory behavior in castrated male rats with a brain-enhanced estradiol-chemical delivery system. Pharmacol Biochem Behav (1987) 0.77
Comparison of different models of rat liver carcinogenesis: conclusions from a systemic analysis. Toxicol Pathol (1984) 0.76
The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis. Carcinogenesis (1988) 0.76
Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments. Carcinogenesis (1991) 0.76
Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach. Pharmazie (2008) 0.76
Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats. Endocr Res (1988) 0.76
Effect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor model. Pharm Res (1997) 0.76
A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. Life Sci (1987) 0.76
Transdermal permeation of neutral molecules by skin electroporation. J Control Release (1998) 0.76
Stable ciliary activity in human nasal epithelial cells grown in a perfusion system. Int J Pharm (2005) 0.76
Promotion of chemically initiated hepatocarcinogenesis. Prog Clin Biol Res (1982) 0.76
Intranasal immunization against influenza virus using polymeric particles. J Biomater Sci Polym Ed (1999) 0.75
Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm (1999) 0.75
Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis. Teratog Carcinog Mutagen (1986) 0.75
Improved delivery through biological membranes. Synthesis, distribution, and neurochemical effects of a tryptamine chemical delivery system. Drug Des Deliv (1986) 0.75
Brain-enhanced delivery of testosterone using a chemical delivery system complexed with 2-hydroxypropyl-beta-cyclodextrin. Drug Des Deliv (1988) 0.75
A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats. Life Sci (1988) 0.75
Partial hepatectomy of rats ten weeks before carcinogen administration can enhance liver carcinogenesis: preliminary observations. Carcinogenesis (1988) 0.75
[Comparative systemic analysis of experimental models of chemical hepatic carcinogenesis in the rat]. C R Seances Soc Biol Fil (1984) 0.75
Adenylate cyclase activity in crude liver membranes during chemical hepatocarcinogenesis. Carcinogenesis (1991) 0.75
Passive diffusion of polymeric surfactants across lipid bilayers. J Control Release (2007) 0.75
Promoting effect of portocaval anastomosis in rat hepatocarcinogenesis. Carcinogenesis (1984) 0.75
Modulation of neoplastic development: concepts and examples. Bull Cancer (1990) 0.75
[Promoting effect of portacaval anastomosis in experimental hepatic carcinogenesis]. C R Seances Soc Biol Fil (1984) 0.75
Dietary modulation of rat liver carcinogenesis. Carcinogenesis (1987) 0.75
Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis. Carcinogenesis (1987) 0.75
Spontaneously self-assembled micelles from poly(ethylene glycol)-b-poly(epsilon-caprolactone-co-trimethylene carbonate) for drug solubilization. Pharmazie (2008) 0.75
Qualitative prediction of solubilization of highly hydrophobic drugs in block copolymer micelles. J Control Release (2005) 0.75